Novel anti-CD73-IL-2v bispecific fusion protein augments antitumor immunity by alleviating immunosuppressive adenosine pathways in CD8<sup>+</sup> T cells
2025 · Journal for ImmunoTherapy of Cancer · 6 citations
https://doi.org/10.1136/jitc-2023-008594